ONCS
Price:
$0.2772
Market Cap:
$1.65M
OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-...[Read more]
Industry
Biotechnology
IPO Date
2010-04-07
Stock Exchange
NASDAQ
Ticker
ONCS
According to OncoSec Medical Incorporated’s latest financial reports and current stock price. The company's current Current Ratio is 0.89. This represents a change of -60.17% compared to the average of 2.24 of the last 4 quarters.
The mean historical Current Ratio of OncoSec Medical Incorporated over the last ten years is 7.71. The current 0.89 Current Ratio has changed 1.06% with respect to the historical average. Over the past ten years (40 quarters), ONCS's Current Ratio was at its highest in in the October 2014 quarter at 31.31. The Current Ratio was at its lowest in in the January 2023 quarter at 0.89.
Average
7.71
Median
5.31
Minimum
2.30
Maximum
28.95
Discovering the peaks and valleys of OncoSec Medical Incorporated Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 891.59%
Maximum Annual Current Ratio = 28.95
Minimum Annual Increase = -62.82%
Minimum Annual Current Ratio = 2.30
Year | Current Ratio | Change |
---|---|---|
2022 | 2.30 | -62.82% |
2021 | 6.18 | 161.94% |
2020 | 2.36 | -58.83% |
2019 | 5.73 | 17.06% |
2018 | 4.89 | 32.79% |
2017 | 3.68 | -56.58% |
2016 | 8.49 | -26.82% |
2015 | 11.60 | -59.94% |
2014 | 28.95 | 891.59% |
2013 | 2.92 | 7.54% |
The current Current Ratio of OncoSec Medical Incorporated (ONCS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.61
5-year avg
4.29
10-year avg
7.71
OncoSec Medical Incorporated’s Current Ratio is greater than ZyVersa Therapeutics, Inc. (0.06), less than Palisade Bio, Inc. (4.31), less than Unicycive Therapeutics, Inc. (3.37), greater than Apexigen, Inc. (0.82), less than Immix Biopharma, Inc. (7.00), less than Phio Pharmaceuticals Corp. (0), less than 180 Life Sciences Corp. (3.47), greater than Navidea Biopharmaceuticals, Inc. (0.58), greater than First Wave BioPharma, Inc. (0.56), less than Dermata Therapeutics, Inc. (1.21), less than Revelation Biosciences, Inc. (2.73), less than Panbela Therapeutics, Inc. (1.10), greater than ContraFect Corporation (0.05), greater than Quoin Pharmaceuticals, Ltd. (0.53), less than Allarity Therapeutics, Inc. (3.35), less than Kiromic BioPharma, Inc. (2.01), greater than Virax Biolabs Group Limited (0.35), less than Biodexa Pharmaceuticals Plc (25.94), less than null (1.26),
Company | Current Ratio | Market cap |
---|---|---|
0.06 | $2.70M | |
4.31 | $4.25M | |
3.37 | $33.41M | |
0.82 | $9.57M | |
7.00 | $54.08M | |
0 | $2.25M | |
3.47 | $1.89M | |
0.58 | $100.08K | |
0.56 | $5.99M | |
1.21 | $2.08M | |
2.73 | $1.43M | |
1.10 | $1.75M | |
0.05 | $1.72M | |
0.53 | $3.06M | |
3.35 | $7.01M | |
2.01 | $3.14M | |
0.35 | $15.24M | |
25.94 | $105.64K | |
1.26 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoSec Medical Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OncoSec Medical Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is OncoSec Medical Incorporated's Current Ratio?
How is the Current Ratio calculated for OncoSec Medical Incorporated (ONCS)?
What is the highest Current Ratio for OncoSec Medical Incorporated (ONCS)?
What is the 3-year average Current Ratio for OncoSec Medical Incorporated (ONCS)?
What is the 5-year average Current Ratio for OncoSec Medical Incorporated (ONCS)?
How does the current Current Ratio for OncoSec Medical Incorporated (ONCS) compare to its historical average?